Comparing Glucommander IV to usual care for treatment of diabetic ketoacidosis. Diabetes in Control interviews Dr. Joseph Aloi.
Use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing Monarch Medical Technologies’ EndoTool with Glytec’s Glucommander. MD Magazine interviews Dr. Valerie Garrett.
How eGMS enables subcutaneous basal bolus insulin therapy and overcomes difficulties of meal-to-meal dosing adjustments. MD Magazine interviews Dr. Jagdeesh Ullal.
Use of Glucommander to prevent medication errors involving insulin. Diabetes in Control interviews Dr. Joseph Aloi.
How Glytec’s evidence strategy achieves improvements in lengths of stay, readmissions, infections and costs. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.